A "Uniquity" good company launch, Eisai is aiming for 13-fold sales growth, and massive tariffs on imported Chinese medical supplies
Novo Nordisk's winning streak continues, Sands Capital closes a $500M+ life science fund, and a Harvard start-up lands 3 big pharma partners.
All your Biotech & Pharma news in one daily email
(Usually) All your Biotech & Pharma news in one daily email
